The offering has already been placed as has the over allotment. This could be an institution slowly unwinding its position or it could be that money is flowing into some of the stocks that are now making new highs or it could be the realization that it is going to take time for CLDX drugs to reach the FDA. Whatever it is, today does not bode well for this stock. Selling begets selling and it has been down here (and lower) in the not too distant past.
These are not unexpected results. For CLDX pps to rise significantly, the results would have had to be unexpectedly impressive. Be happy the results were not discouraging and the stock isn't at $12 this morning.
The problem when you correct someone else's mistake is that you often make a mistake yourself! You say it is not two dog's. if it were the possessive of two dogs, it would be two dogs '- not two dog's, as you write. For instance, if you were answering the question about whose food bowel was sitting on the floor, you would say it's the two dogs' if it belonged to the two dogs.
Today will not be the next big deflation day. When it drops, it will drop 4 or 5 points in a day. People are hanging on in the hope it pops up a buck so they can salvage a little more and, for some, reality hasn't yet set in. When they get a margin call or realize there will be no dramatic turn around, they will dump. It will probably close near where it is now unless it starts to collapse and make a new day low. If that happens, panic will set in and there will major selling into the close.
I suggest you read the article at Forbes. It very calmly and clearly lays out the risk and the reward and makes clear that the reward won't be coming anytime soon.
SRPT has 187,66 in cash and cash equivalents, not 300 million in cash. Read the balance sheet and note its liabilities.
and those who don't seem to realize that every time it rises, people sell it off. I would b surprised if it doesn't make a new low by the close.
Read the balance sheet: under $6 in cash and the other poster is correct: they are burning cash at a high rate.
Could we put an end to these ridiculous and differing cash values? The company has 187,661 million in cash or cash equivalents and 33.53 million shares. Divide the cash by the shares and you get - exactly: $5.97.
Apparently, you can't read a balance sheet. They have 187 mil in cash and cash equivalents and 33 million shares.
This isn't going to squeeze anywhere. If you read what the FDA actually said about the application, you will see that drug is not going to get approval. When you invest in bio, you need to take your loss and move on. There are plenty of bio tech companies with incredible potential and multiple drugs in the pipeline that already show promise: for instance, CLDX. When investing in such companies, it is wise to look at how the successful ones grew: VRUS, AEGR, etc. SRPT does not have the characteristics those companies had, while CLDX does. I'm not in SRPT, but I have had my share of disasters. It is high risk high reward investing and there is nothing worse than turning a disaster into a long term dead money hold. Praying and hoping doesn't help. SRPT will be below 10 in the coming weeks and it won't recover anytime soon, if ever.